Ultima OPCAB System, Sterile, Rx Only, Product Usage: Intended for use during performance of minimally invasive cardiac surgery through a sternotomy incision approach. The ULTIMA Access RailPlatform in combination with the Activator II Drive Mechanism is used to spread the sternum, providing access and direct visualization to the thoracic cavity. The AccessRail Platform also allows for the organization of pericardial sutures. The ULTIMA Stablizer isolates and provides local immobilization of the target vessel on the beating heart.
Publicado el 9 de octubre de 2013 · Inicio del retiro: 20 de septiembre de 2013
Resumen
FDA registra el retiro Z-0001-2014 de dispositivos médicos de Clase II, publicado el 9 de octubre de 2013 e iniciado el 20 de septiembre de 2013. Empresa responsable: Maquet Cardiovascular, LLC; Estado: Finalizado; Cantidad reportada: 20 units (Lot 25052176); 12 units (Lot #25052200); Lote: ULTIMA OPCAB System Part Nos. OM-2003S (LOT #25052176) and OM-2001D (LOT #25052200). La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
MAQUET has identified a potential issue with the ULTIMA OPCAB (part numbers OM-2003S & OM-2001D). Labeling for the 2 blade lots had been incorrectly applied. The standard blades from Lot #25052176 were incorrectly labeled as deep blades, and the 20 deep blades from Lot #25052200 were incorrectly labeled as standard blades.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Maquet Cardiovascular, LLC
- Distribuidor
- USA Nationwide Distribution in the states of: Florida, Maryland, New Jersey, New York and Texas.
- Lote
- ULTIMA OPCAB System Part Nos. OM-2003S (LOT #25052176) and OM-2001D (LOT #25052200).
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAThe Vasoview Hemopro 2 Endoscopic Vessel Harvesting System (Model VH-4000; UDI 00607567700406) is a sterile,22 de julio de 2026
- FDAVasoview Hemopro 3 Endoscopic Vessel Harvesting System Model No. C-VH-6000. The VASOVIEW HEMOPRO 3 Endoscopic1 de octubre de 2025
- FDAAcrobat-i Positioner. Model Number C-XP-5000Z27 de noviembre de 2024
- FDAAcrobat SUV Vacuum Stabilizer System, ST. Model Number C-OM-9000Z27 de noviembre de 2024
- FDATully's House Blend Decaffeinated K-Cup® Packs (12-ct retail box) Product Code: 8803; UPC: 0995550880389 de octubre de 2013
- FDAKing LTS-D Oropharyngeal Airways Product Usage: The King LTS-D is intended for use in adult patients (in9 de octubre de 2013
Preguntas sobre este retiro
¿Ultima OPCAB System, Sterile, Rx Only, Product Usage: Intended for use during performance of minimally invasive cardiac surgery through a sternotomy incision approach. The ULTIMA Access RailPlatform in combination with the Activator II Drive Mechanism is used to spread the sternum, providing access and direct visualization to the thoracic cavity. The AccessRail Platform also allows for the organization of pericardial sutures. The ULTIMA Stablizer isolates and provides local immobilization of the target vessel on the beating heart. fue retirado del mercado?
Sí. FDA publicó el retiro Z-0001-2014 el 9 de octubre de 2013. Peligro reportado: MAQUET has identified a potential issue with the ULTIMA OPCAB (part numbers OM-2003S & OM-2001D). Labeling for the 2 blade lots had been incorrectly applied. The standard blades from Lot #25052176 were incorrectly labeled as deep blades, and the 20 deep blades from Lot #25052200 were incorrectly labeled as standard blades.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter